BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31470076)

  • 1. Time to first cigarette of the day and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in adult regular and non-daily smokers: (NHANES) 2007-10.
    Branstetter SA; Nye RT; Muscat JE
    Regul Toxicol Pharmacol; 2019 Nov; 108():104454. PubMed ID: 31470076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to first cigarette predicts 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in adolescent regular and intermittent smokers, National Health and Nutrition and Examination Survey (NHANES) 2007-10.
    Branstetter SA; Mercincavage M; Muscat JE
    Addiction; 2014 Jun; 109(6):1005-12. PubMed ID: 24521204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to Nicotine and Toxicants Among Dual Users of Tobacco Cigarettes and E-Cigarettes: Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.
    Smith DM; Christensen C; van Bemmel D; Borek N; Ambrose B; Erives G; Niaura R; Edwards KC; Stanton CA; Blount BC; Wang L; Feng J; Jarrett JM; Ward CD; Hatsukami D; Hecht SS; Kimmel HL; Travers M; Hyland A; Goniewicz ML
    Nicotine Tob Res; 2021 May; 23(5):790-797. PubMed ID: 33590857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of Cotinine and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in U.S. Non-Daily Cigarette Smokers.
    Gutiérrez-Torres DS; Wang L; Blount BC; Xia B; Sosnoff CS; Shiels MS; Inoue-Choi M; Etemadi A; Freedman ND
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1165-1174. PubMed ID: 33737303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
    Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
    Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to first cigarette and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) levels in adult smokers; National Health and Nutrition Examination Survey (NHANES), 2007-2010.
    Branstetter SA; Muscat JE
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):615-22. PubMed ID: 23542804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of nicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone (NNK) in menthol and non-menthol cigarette smokers.
    Sarkar M; Wang J; Liang Q
    Drug Metab Lett; 2012 Sep; 6(3):198-206. PubMed ID: 23140558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Pod e-Cigarettes vs Cigarettes on Carcinogen Exposure Among African American and Latinx Smokers: A Randomized Clinical Trial.
    Pulvers K; Nollen NL; Rice M; Schmid CH; Qu K; Benowitz NL; Ahluwalia JS
    JAMA Netw Open; 2020 Nov; 3(11):e2026324. PubMed ID: 33206193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Black Light Smokers: How Nicotine Intake and Carcinogen Exposure Differ Across Various Biobehavioral Factors.
    St Helen G; Benowitz NL; Ahluwalia JS; Tyndale RF; Addo N; Gregorich SE; Pérez-Stable EJ; Cox LS
    J Natl Med Assoc; 2019 Oct; 111(5):509-520. PubMed ID: 31084916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
    Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
    J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.
    Ashley DL; O'Connor RJ; Bernert JT; Watson CH; Polzin GM; Jain RB; Hammond D; Hatsukami DK; Giovino GA; Cummings KM; McNeill A; Shahab L; King B; Fong GT; Zhang L; Xia Y; Yan X; McCraw JM
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1389-98. PubMed ID: 20501750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
    Joseph AM; Hecht SS; Murphy SE; Carmella SG; Le CT; Zhang Y; Han S; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2963-8. PubMed ID: 16365017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicant exposure in cigarette reducers versus light smokers.
    Hatsukami DK; Le CT; Zhang Y; Joseph AM; Mooney ME; Carmella SG; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2355-8. PubMed ID: 17164356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Users Compared to Smokers: Demographics, Dependence, and Biomarkers.
    Piper ME; Baker TB; Benowitz NL; Kobinsky KH; Jorenby DE
    Nicotine Tob Res; 2019 Aug; 21(9):1279-1284. PubMed ID: 30365010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette rod length and its impact on serum cotinine and urinary total NNAL levels, NHANES 2007-2010.
    Agaku IT; Vardavas CI; Connolly GN
    Nicotine Tob Res; 2014 Jan; 16(1):100-7. PubMed ID: 24057994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NNAL exposure by race and menthol cigarette use among U.S. smokers.
    Rostron B
    Nicotine Tob Res; 2013 May; 15(5):950-6. PubMed ID: 23089487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes.
    Bernert JT; Jain RB; Pirkle JL; Wang L; Miller BB; Sampson EJ
    Nicotine Tob Res; 2005 Oct; 7(5):729-38. PubMed ID: 16191744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese 'low-tar' cigarettes do not deliver lower levels of nicotine and carcinogens.
    Gan Q; Lu W; Xu J; Li X; Goniewicz M; Benowitz NL; Glantz SA
    Tob Control; 2010 Oct; 19(5):374-9. PubMed ID: 20507920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
    Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
    Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.